Related Experiment Video
Updated: May 6, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Increased soluble vascular adhesion molecule-1 concentration is associated with impaired coronary flow reserve in
Byung Ju Shim1, Dong Hyeon Lee, Ho Joong Youn
1Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Insights
Early atherosclerosis markers like soluble vascular cell adhesion molecule-1 (sVCAM-1) are inversely associated with coronary flow reserve (CFR) in cardiac syndrome X patients. This suggests sVCAM-1 may indicate subclinical coronary atherosclerosis.
Area of Science:
- Cardiology
- Vascular Biology
- Inflammation Research
Background:
- Endothelial dysfunction and inflammation drive atherosclerosis.
- Coronary flow reserve (CFR) assesses coronary microcirculation function.
- Cardiac Syndrome X involves chest pain with normal coronary angiograms, often linked to microvascular dysfunction.
Purpose of the Study:
- To investigate the association between early atherosclerotic inflammatory markers and CFR.
- To evaluate soluble vascular cell adhesion molecule-1 (sVCAM-1) in relation to CFR in cardiac syndrome X.
Main Methods:
- 135 cardiac syndrome X patients underwent transthoracic echocardiography (TTE) for CFR assessment.
- Blood samples measured inflammatory biomarkers: sVCAM-1, IL-6, MCP-1, Lp-PLA2.
- CFR was measured using TTE with adenosine or dipyridamole within two weeks of coronary angiography.
Main Results:
- An inverse correlation was found between sVCAM-1 and CFR (r = -0.225, P = 0.014).
- Patients with CFR < 2.0 had significantly higher sVCAM-1 levels (757 ± 323 ng/ml) compared to those with CFR ≥ 2.0 (628 ± 146 ng/ml, P = 0.007).
- Multivariate analysis identified sVCAM-1 as an independent factor related to CFR < 2.0 (OR 1.003, P = 0.023).
Conclusions:
- sVCAM-1 levels are inversely associated with CFR in cardiac syndrome X patients.
- Elevated sVCAM-1 may reflect subclinical coronary atherosclerosis and microvascular dysfunction.
- Further research is needed to confirm sVCAM-1's role as an inflammatory modulator in early atherosclerosis.
Abstract:
It is well known that both atherosclerosis initiated by endothelial dysfunction due to inflammatory cascade and coronary flow reserve (CFR) are useful in the functional or risk assessment of coronary microcirculation. The aim of this study is to elucidate the association between early atherosclerotic inflammatory markers and CFR using transthoracic echocardiography (TTE) in subjects with cardiac syndrome X. A total of 135 individuals (mean age 56 ± 9 years, 79 males and 56 females) with angina or angina-like chest pain and a normal coronary angiogram were enrolled. The early inflammatory biomarkers related to atherosclerosis, namely soluble vascular adhesion molecule-1 (sVCAM-1), interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and lipoprotein-associated phospholipase A2 (Lp-PLA2), were compared with analyzed CFR, using TTE and adenosine or dipyridamole, measured within 2 weeks after coronary angiography. There was an inverse correlation between sVCAM-1 and CFR (r = -0.225, P = 0.014). In the two groups divided by a CFR of 2.0, sVCAM-1 was significantly higher in the group with CFR <2.0 than in the group with CFR ≥2.0 (n = 21: 757 ± 323 ng/ml, vs n = 114: 628 ± 146 ng/ml, P = 0.007). In multivariate analysis, sVCAM-1 was an independent factor related to a CFR <2.0 (odds ratio 1.003, 95 % confidence interval 1.001-1.006, P = 0.023). Our results showed that sVCAM-1 levels were inversely associated with CFR using TTE in cardiac syndrome X. Further studies are warranted to validate whether increased sVCAM-1 concentration, as an inflammatory modulator, is reflected in the presence of subclinical coronary atherosclerosis.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

